Hwanin Pharmaceutical Reports Q2 Operating Profit of 5.6 Billion KRW, Down 15% YoY

[Asia Economy Reporter Minji Lee] Hwanin Pharmaceutical announced on the 10th that its operating profit for the second quarter was 5.623 billion KRW, a 15.2% decrease compared to the same period last year. Sales increased by 4% from a year earlier to 42.124 billion KRW, and net profit for the period rose 70.9% to 4.745 billion KRW.